About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Current Opinion in Oncology
›
top-articles
Current Opinion in Oncology
2.9
(top 20%)
impact factor
3.2K
(top 10%)
papers
74.0K
(top 5%)
citations
102
(top 5%)
h
-index
3.0
(top 20%)
impact factor
4.0K
all documents
77.1K
doc citations
151
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
TGF-β signaling and epithelial–mesenchymal transition in cancer progression
Current Opinion in Oncology
2013
698
2
Histone deacetylase inhibitors as new cancer drugs
Current Opinion in Oncology
2001
482
3
Oncogenic PI3K and its role in cancer
Current Opinion in Oncology
2006
454
4
Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
Current Opinion in Oncology
1995
422
5
Heat shock protein 90
Current Opinion in Oncology
2003
365
6
Telomerase activity in human cancer
Current Opinion in Oncology
1996
335
7
Multidrug resistance transporters and modulation
Current Opinion in Oncology
2000
333
8
Mechanisms of apoptosis avoidance in cancer
Current Opinion in Oncology
1999
312
9
Multiple roles of the tumor suppressor p53
Current Opinion in Oncology
2002
301
10
Glucose transporters in cancer metabolism
Current Opinion in Oncology
2012
288
11
Sarcomas of the head and neck region
Current Opinion in Oncology
2003
263
12
p21WAF1 and tumourigenesis
Current Opinion in Oncology
2013
255
13
Recent changes in the epidemiology of head and neck cancer
Current Opinion in Oncology
2009
251
14
Human papillomavirus–associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers
Current Opinion in Oncology
2001
248
15
Radiation-induced and chemotherapy-induced pulmonary injury
Current Opinion in Oncology
2001
240
16
New molecular insights into osteosarcoma targeted therapy
Current Opinion in Oncology
2013
240
17
The management of brain edema in brain tumors
Current Opinion in Oncology
2004
239
18
Doctor-patient communication and satisfaction with care in oncology
Current Opinion in Oncology
2005
237
19
Biobanking: the foundation of personalized medicine
Current Opinion in Oncology
2011
236
20
Epidermal growth factor receptor biology (IMC-C225)
Current Opinion in Oncology
2001
225
21
Microsatellite instability in inherited and sporadic neoplasms
Current Opinion in Oncology
1995
221
22
Use of rituximab, the new FDA-approved antibody
Current Opinion in Oncology
1998
215
23
The MAPK pathway in melanoma
Current Opinion in Oncology
2008
215
24
Mucositis
Current Opinion in Oncology
2015
213
25
Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies
Current Opinion in Oncology
2016
213
26
Current status of interleukin-10 and regulatory T-cells in cancer
Current Opinion in Oncology
2013
211
27
Regulation of Bcl-xL: a little bit of this and a little bit of STAT
Current Opinion in Oncology
2000
210
28
Aneuploidy and cancer
Current Opinion in Oncology
2000
210
29
Targeting the hallmarks of cancer
Current Opinion in Oncology
2013
209
30
The changing epidemiology of thyroid cancer
Current Opinion in Oncology
2015
209
31
Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma
Current Opinion in Oncology
2011
203
32
Update on neurological paraneoplastic syndromes
Current Opinion in Oncology
2015
192
33
Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future
Current Opinion in Oncology
2008
191
34
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
Current Opinion in Oncology
2007
190
35
Surgery of low-grade gliomas: towards a ‘functional neurooncology’
Current Opinion in Oncology
2009
187
36
Ba/F3 cells and their use in kinase drug discovery
Current Opinion in Oncology
2007
185
37
Tumor-cell-derived microvesicles as carriers of molecular information in cancer
Current Opinion in Oncology
2013
185
38
Molecular pathogenesis of malignant gliomas
Current Opinion in Oncology
1999
184
39
Different mechanisms in the tumorigenesis of proximal and distal colon cancers
Current Opinion in Oncology
2001
182
40
Cancer therapy and p53
Current Opinion in Oncology
1995
180
41
Targeting EZH2 in cancer therapy
Current Opinion in Oncology
2017
179
42
Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract
Current Opinion in Oncology
2000
172
43
Patient-physician communication in oncology: past, present, and future
Current Opinion in Oncology
2005
171
44
Interferons: mechanisms of action and clinical applications
Current Opinion in Oncology
2003
166
45
Epidemiology of head and neck cancers: an update
Current Opinion in Oncology
2020
166
46
The role of beta-catenin in cell adhesion, signal transduction, and cancer
Current Opinion in Oncology
1998
164
47
The Warburg effect in 2012
Current Opinion in Oncology
2012
164
48
Duel nature of TGF-?? signaling: tumor suppressor vs. tumor promoter
Current Opinion in Oncology
2005
161
49
Carney complex: the first 20 years
Current Opinion in Oncology
2007
161
50
STAT proteins as novel targets for cancer therapy
Current Opinion in Oncology
1999
160
site/software ©
exaly
; All materials licenced under
CC by-SA
.